Medtronic (MDT +1.3%) moves up today after saying it's initiated enrollment of the first patient...

|About: Medtronic plc (MDT)|By:, SA News Editor

Medtronic (MDT +1.3%) moves up today after saying it's initiated enrollment of the first patient in its SubQStim II clinical trial which uses peripheral nerve stimulation, also known as subcutaneous nerve stimulation, to reduce chronic, intractable post-surgical back pain.